stockportfolio.pro
Stocks / IONS vs SOLV
IONS vs SOLV
Ionis Pharmaceuticals, Inc. and Solventum Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
SOLV is the larger company ($12.9B vs $12.2B). On the fundamentals, IONS grows revenue faster (5.3% vs 0.8%); SOLV earns a higher net margin (18.7% vs -40.4%); SOLV has the stronger return on equity (30.8% vs -78.0%). Full numbers below — the stronger figure on each row is in green.
| Ionis Pharmaceuticals, Inc. (IONS) | Solventum Corporation (SOLV) | |
|---|---|---|
| Market cap | $12.2B | $12.9B |
| Revenue (latest FY) | $943.71M | $8.32B |
| Net income (latest FY) | $-381.39M | $1.56B |
| Revenue growth (5y CAGR) | 5.3% | 0.8% |
| Net margin | -40.4% | 18.7% |
| Return on equity | -78.0% | 30.8% |
| P/E ratio | — | 9.1 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 3 | 4 |
| Positive free cash flow | No | No |
Compare with another company:
See the full IONS vs SOLV breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open IONS's full financials → Open SOLV's full financials →More comparisons
Frequently asked questions
Which is bigger, IONS or SOLV?
Solventum Corporation is larger by market capitalization — $12.9B versus $12.2B.
Which grows faster, IONS or SOLV?
Over the last five fiscal years, Ionis Pharmaceuticals, Inc. grew revenue faster — 5.3%/yr versus 0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.